William Lis - 12 Oct 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
4
Filing time
13 Oct 2022, 19:58:35 UTC
Previous filing
28 Jun 2022
Next filing
07 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Award $0 +29,500 +73% $0.000000 69,986 12 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.